Lifecore Biomedical, Inc. De

LFCRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$242.408 M

$6.40 -0.70%

Close of 6 Nov 2026

As of 6 Nov 2026, Lifecore Biomedical, Inc. De (LFCR) has a market capitalization of $242.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$38.7M

Loss-making

Shares outstanding

37,905,846

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#232Larimar TherapeuticsLRMR$244.6M
#233Bicycle TherapeuticsBCYC$243.9M
#234Lifecore Biomedical, Inc. DeLFCR$242.4M
#235Amarin Corp PlcukAMRN$238.3M
#236Camp4 TherapeuticsCAMP$233.4M

What if Lifecore Biomedical, Inc. De were worth as much as…

Open the what-if tool →

Gold $28.2T

$744,921.35

Per share 116,485× higher

Bitcoin $1.53T

$40,306.40

Per share 6,303× higher

Apple $5.02T

$132,322.14

Per share 20,691× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Lifecore Biomedical, Inc. De are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.